Skip to content

Clinical trials

Phase 2 Disease trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Disease Phase: Phase 2 Clear all

102 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20033
20043
20052
20063
20074
20085
20094
20104
20111
20123
20142
20164
20175
20184
20196
20207
20214
20224
20235
20243
202511
202611

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed54
Recruiting19
Not yet recruiting10
Active, not recruiting5
Terminated5
Withdrawn5
Unknown status4

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Institute for Neurodegenerative Disorders5
Dascena4
National Cancer Institute (NCI)3
Dey2
European Myeloma Network B.V.2
Lyra Therapeutics2
M.D. Anderson Cancer Center2
Sanofi2
Seattle Institute for Biomedical and Clinical Research2
The First Affiliated Hospital with Nanjing Medical University2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Disease102
Breast Neoplasms6
Asthma5
Neoplasms5
Parkinsonian Disorders5
Prostatic Neoplasms5
Stomach Neoplasms5
Glioma4
Leukemia, Myeloid, Acute4
Sepsis4

Trials

Showing 26 to 50 of 102. Each trial links to its page on Pharma Observatory.

2 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.